Eagle Pointome Non Current Assets Total Over Time
| EICB Stock | 24.99 0.03 0.12% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Eagle Pointome Performance and Eagle Pointome Correlation. Eagle |
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eagle Pointome. If investors know Eagle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eagle Pointome listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.601 | Revenue Per Share 2.259 | Quarterly Revenue Growth 0.896 | Return On Assets 0.0668 | Return On Equity 0.2644 |
The market value of Eagle Pointome is measured differently than its book value, which is the value of Eagle that is recorded on the company's balance sheet. Investors also form their own opinion of Eagle Pointome's value that differs from its market value or its book value, called intrinsic value, which is Eagle Pointome's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eagle Pointome's market value can be influenced by many factors that don't directly affect Eagle Pointome's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eagle Pointome's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eagle Pointome is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eagle Pointome's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Non Current Assets Total Analysis
Compare Eagle Pointome and related stocks such as Cumberland Pharmaceuticals, Electrovaya Common Shares, and Merit Medical Systems Non Current Assets Total Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CPIX | 1.6 M | 8.2 M | 11.4 M | 18.9 M | 24.6 M | 24.8 M | 27.9 M | 24.5 M | 37.8 M | 54.4 M | 46.5 M | 38.8 M | 47.1 M | 46.1 M | 27.5 M |
| ELVA | 317 K | 10.8 M | 9.8 M | 9 M | 7.7 M | 7.5 M | 12.8 M | 11.5 M | 5 K | 2.6 M | 2.9 M | 7.4 M | 10.6 M | 9.5 M | 6.2 M |
| MMSI | 800 K | 313.4 M | 543.3 M | 562.4 M | 554.8 M | 574.7 M | 699.4 M | 795.7 M | 1.2 B | 1.3 B | 1.2 B | 1.2 B | 1.1 B | 1.2 B | 1.3 B |
| XPOF | 294.1 M | 294.1 M | 294.1 M | 294.1 M | 294.1 M | 294.1 M | 294.1 M | 294.1 M | 294.1 M | 294.1 M | 290.1 M | 364.3 M | 397 M | 431.4 M | 390.9 M |
| GFF | 40.3 M | 980 M | 964.4 M | 1 B | 974.6 M | 1 B | 775.4 M | 1.2 B | 1.1 B | 1.3 B | 1.2 B | 1.6 B | 1.4 B | 1.4 B | 1.5 B |
| ALVO | 388.3 M | 388.3 M | 388.3 M | 388.3 M | 388.3 M | 388.3 M | 388.3 M | 388.3 M | 388.3 M | 388.3 M | 388.3 M | 478.2 M | 597.7 M | 755.2 M | 610.3 M |
| OMHE | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| SSY | 5 M | 48.6 M | 39.9 M | 38.1 M | 32 M | 26.9 M | 12.7 M | 13.1 M | 7.8 M | 8 M | 9.6 M | 11.1 M | 11 M | 4.9 M | 4.7 M |
Eagle Pointome and related stocks such as Cumberland Pharmaceuticals, Electrovaya Common Shares, and Merit Medical Systems Non Current Assets Total description
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.My Equities
My Current Equities and Potential Positions
| Eagle Pointome | EICB |
Specialization | Financial Services, Financial Services |
| Location | Connecticut; U.S.A |
| Exchange | New York Stock Exchange |
null 24.99
Check out Eagle Pointome Performance and Eagle Pointome Correlation. For information on how to trade Eagle Stock refer to our How to Trade Eagle Stock guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Eagle Pointome technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.